Cargando…
Lateral membrane organization as target of an antimicrobial peptidomimetic compound
Antimicrobial resistance is one of the leading concerns in medical care. Here we study the mechanism of action of an antimicrobial cationic tripeptide, AMC-109, by combining high speed-atomic force microscopy, molecular dynamics, fluorescence assays, and lipidomic analysis. We show that AMC-109 acti...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10328936/ https://www.ncbi.nlm.nih.gov/pubmed/37419980 http://dx.doi.org/10.1038/s41467-023-39726-5 |
_version_ | 1785069913548783616 |
---|---|
author | Melcrová, Adéla Maity, Sourav Melcr, Josef de Kok, Niels A. W. Gabler, Mariella van der Eyden, Jonne Stensen, Wenche Svendsen, John S. M. Driessen, Arnold J. M. Marrink, Siewert J. Roos, Wouter H. |
author_facet | Melcrová, Adéla Maity, Sourav Melcr, Josef de Kok, Niels A. W. Gabler, Mariella van der Eyden, Jonne Stensen, Wenche Svendsen, John S. M. Driessen, Arnold J. M. Marrink, Siewert J. Roos, Wouter H. |
author_sort | Melcrová, Adéla |
collection | PubMed |
description | Antimicrobial resistance is one of the leading concerns in medical care. Here we study the mechanism of action of an antimicrobial cationic tripeptide, AMC-109, by combining high speed-atomic force microscopy, molecular dynamics, fluorescence assays, and lipidomic analysis. We show that AMC-109 activity on negatively charged membranes derived from Staphylococcus aureus consists of two crucial steps. First, AMC-109 self-assembles into stable aggregates consisting of a hydrophobic core and a cationic surface, with specificity for negatively charged membranes. Second, upon incorporation into the membrane, individual peptides insert into the outer monolayer, affecting lateral membrane organization and dissolving membrane nanodomains, without forming pores. We propose that membrane domain dissolution triggered by AMC-109 may affect crucial functions such as protein sorting and cell wall synthesis. Our results indicate that the AMC-109 mode of action resembles that of the disinfectant benzalkonium chloride (BAK), but with enhanced selectivity for bacterial membranes. |
format | Online Article Text |
id | pubmed-10328936 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-103289362023-07-09 Lateral membrane organization as target of an antimicrobial peptidomimetic compound Melcrová, Adéla Maity, Sourav Melcr, Josef de Kok, Niels A. W. Gabler, Mariella van der Eyden, Jonne Stensen, Wenche Svendsen, John S. M. Driessen, Arnold J. M. Marrink, Siewert J. Roos, Wouter H. Nat Commun Article Antimicrobial resistance is one of the leading concerns in medical care. Here we study the mechanism of action of an antimicrobial cationic tripeptide, AMC-109, by combining high speed-atomic force microscopy, molecular dynamics, fluorescence assays, and lipidomic analysis. We show that AMC-109 activity on negatively charged membranes derived from Staphylococcus aureus consists of two crucial steps. First, AMC-109 self-assembles into stable aggregates consisting of a hydrophobic core and a cationic surface, with specificity for negatively charged membranes. Second, upon incorporation into the membrane, individual peptides insert into the outer monolayer, affecting lateral membrane organization and dissolving membrane nanodomains, without forming pores. We propose that membrane domain dissolution triggered by AMC-109 may affect crucial functions such as protein sorting and cell wall synthesis. Our results indicate that the AMC-109 mode of action resembles that of the disinfectant benzalkonium chloride (BAK), but with enhanced selectivity for bacterial membranes. Nature Publishing Group UK 2023-07-07 /pmc/articles/PMC10328936/ /pubmed/37419980 http://dx.doi.org/10.1038/s41467-023-39726-5 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Melcrová, Adéla Maity, Sourav Melcr, Josef de Kok, Niels A. W. Gabler, Mariella van der Eyden, Jonne Stensen, Wenche Svendsen, John S. M. Driessen, Arnold J. M. Marrink, Siewert J. Roos, Wouter H. Lateral membrane organization as target of an antimicrobial peptidomimetic compound |
title | Lateral membrane organization as target of an antimicrobial peptidomimetic compound |
title_full | Lateral membrane organization as target of an antimicrobial peptidomimetic compound |
title_fullStr | Lateral membrane organization as target of an antimicrobial peptidomimetic compound |
title_full_unstemmed | Lateral membrane organization as target of an antimicrobial peptidomimetic compound |
title_short | Lateral membrane organization as target of an antimicrobial peptidomimetic compound |
title_sort | lateral membrane organization as target of an antimicrobial peptidomimetic compound |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10328936/ https://www.ncbi.nlm.nih.gov/pubmed/37419980 http://dx.doi.org/10.1038/s41467-023-39726-5 |
work_keys_str_mv | AT melcrovaadela lateralmembraneorganizationastargetofanantimicrobialpeptidomimeticcompound AT maitysourav lateralmembraneorganizationastargetofanantimicrobialpeptidomimeticcompound AT melcrjosef lateralmembraneorganizationastargetofanantimicrobialpeptidomimeticcompound AT dekoknielsaw lateralmembraneorganizationastargetofanantimicrobialpeptidomimeticcompound AT gablermariella lateralmembraneorganizationastargetofanantimicrobialpeptidomimeticcompound AT vandereydenjonne lateralmembraneorganizationastargetofanantimicrobialpeptidomimeticcompound AT stensenwenche lateralmembraneorganizationastargetofanantimicrobialpeptidomimeticcompound AT svendsenjohnsm lateralmembraneorganizationastargetofanantimicrobialpeptidomimeticcompound AT driessenarnoldjm lateralmembraneorganizationastargetofanantimicrobialpeptidomimeticcompound AT marrinksiewertj lateralmembraneorganizationastargetofanantimicrobialpeptidomimeticcompound AT rooswouterh lateralmembraneorganizationastargetofanantimicrobialpeptidomimeticcompound |